Retinal diseases among the adult population in federal statistics of the Russian Federation

The incidence rates, as well as certain aspects of the organization of medical care for patients with retinal diseases, are collected in the main forms of federal statistical observation. These data are important not only from the point of view of assessing the epidemiology of diseases, but primarily as indicators of the quality and accessibility of medical care.

The purpose is to analyze the overall incidence of retinal diseases based on data from the federal statistical observation forms for the Russian Federation in 2024 in comparison with data from global epidemiological studies.

Material and methods. We studied the indicators of general morbidity presented in the forms of statistical observation of the Russian Federation in 2024, analyzed the indicators by region of the country and compared the average Russian data with the results of international epidemiological studies.

Results. The analysis of federal statistics data has shown the relevance of the problem of accounting for retinal diseases. In the Russian Federation in 2024, there were registered in absolute figures 368,358 adult patients with macular degeneration (relative indicator — 317.0 per 100,000 adult population), 34,769 adult patients with degenerative myopia (29.9 per 100,000 adult population), 459,327 adult patients with diabetic retinopathy (399.6 per 100,000 adult population), 39,751 adult patients with rhegmatogenous retinal detachment (34.2 per 100,000 adult population), 9,799 adult patients with chorioretinal inflammation (8.4 per 100,000 adult population).

Conclusion. Retinal pathology has a fairly high prevalence and accounts for a significant proportion of hospital morbidity. The deviation of statistical indicators from the data of global epidemiological studies, including in certain regions of the Russian Federation, indicates defects in the coding, diagnosis and accounting of diseases.

1. GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021; 9 (2): 130–43. doi: 10.1016/S2214-109X(20)30425-3

2. Wong WL, Su X, Li X et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2 (2): 106–16. doi: 10.1016/S2214-109X(13)70145-1

3. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology. 2002; 109 (10): 1767–79. doi: 10.1016/s0161-6420(02)01146-6

4. Age-related macular degeneration (CR114_3). Clinical recommendations (treatment protocols). All-Russian public organization “Association of Ophthalmologists” (In Russ.)]. Available at: https://cr.minzdrav.gov.ru/view-cr/114_3 (Electronic resource) (accessed 20.02.2025)

5. Myopic macular degeneration (CR782_1). Clinical recommendations (treatment protocols). All-Russian public organization “Association of Ophthalmologists” (In Russ.). Available at: https://cr.minzdrav.gov.ru/view-cr/782_1 (Electronic resource) (accessed 20.02.2025)

6. Friedman NJ, Kaiser PK. Essentials of Ophthalmology. Philadelphia, PA: Elsevier Inc; 2007: 253–4.

7. Ohsugi H, Ikuno Y, Shoujou T, et al. Axial length changes in highly myopic eyes and influence of myopic macular complications in Japanese adults. PLoS One. 2017; 12 (7): e0180851. doi: 10.1371/journal.pone.0180851

8. Pan CW, Dirani M, Cheng CY, Wong TY, Saw SM. The age-specific prevalence of myopia in Asia: a meta-analysis. Optom Vis Sci. 2015; 92 (3): 258–66. doi: 10.1097/OPX.0000000000000516.

9. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984; 102 (4): 527–32. doi: 10.1001/archopht.1984.01040030405011

10. Dedov I.I., Shestakova M.V., Mayorov A.Yu., eds. Standards of specialized diabetes care. Clinical guidelines. 9th Edition (revised). Moscow; 2019 (In Russ.). doi:10.14341/DM221S

11. Li JQ, Welchowski T, Schmid M, et al. Incidence of rhegmatogenous retinal detachment in Europe — a systematic review and meta-analysis. Ophthalmologica. 2019; 242 (2): 81–6. doi: 10.1159/000499489

12. Non-infectious uveitis (CR787_1). Clinical recommendations (treatment protocols). All-Russian public organization “Association of phthalmologists” (In Russ.). Available at: https://cr.minzdrav.gov.ru/view-cr/787_1 (Electronic resource) (accessed 20.02.2025)

13. Smet MD, Taylor SR, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011; 30 (6): 452–70. https://doi.org/10.1016/j.preteyeres.2011.06.005

14. Acharya NR, Tham VM, Esterberg E, et al. Incidence and prevalence of uveitis: resultsfrom the Pacific Ocular Inflammation Study. JAMA Ophthalmol. 2013; 131 (11): 1405–12. https://doi.org/10.1001/jamaophthalmol.2013.4237

15. Hsu YR, Huang JC, Tao Y, et al. Noninfectious uveitis in the Asia-Pacific region. Eye (Lond). 2019; 33 (1): 66–77. doi: 10.1038/s41433-018-0223-z

16. London NJ, Rathinam SR, Cunningham ET Jr. The epidemiology of uveitis in developing country. Int Ophthalmol Clin. 2010; 50 (2): 1–17. https://doi.org/10.1097/iio.0b013e3181d2cc6b

17. Miserocchi E, Fogliato G, Modorati G, Bandello F. Review on the world wide epidemiology of uveitis. Eur J Ophthalmol. 2013; 23 (5): 705–17. https://doi.org/10.5301/ejo.5000278